![]() |
![]() |
Legal status
Patent lapsed (non-payment of fees)
(51) | INT.CL. | C07D 473/04 | (2006.01) |
C07D 473/06 | (2006.01) | ||
A61K 31/522 | (2006.01) | ||
A61P 9/00 | (2006.01) |
(11) | Number of the document | 1781657 |
(13) | Kind of document | T |
(96) | European patent application number | 05707363.7 |
Date of filing the European patent application | 2005-02-10 | |
(97) | Date of publication of the European application | 2007-05-09 |
(45) | Date of publication and mention of the grant of the patent | 2013-03-27 |
(46) | Date of publication of the claims translation | 2013-06-25 |
(86) | Number | PCT/EP2005/001449 |
Date | 2005-02-10 |
(87) | Number | WO 2005/077950 |
Date | 2005-08-25 |
(30) | Number | Date | Country code |
0403282 | 2004-02-14 | GB | |
0423562 | 2004-10-22 | GB | |
0428375 | 2004-12-24 | GB |
(72) |
PINTO, Ivan Leo, GB
RAHMAN, Shahzad Sharooq, GB
NICHOLSON, Neville Hubert, GB
|
(73) |
GlaxoSmithKline Intellectual Property Development Limited,
980 Great West Road, Brentford Middlesex TW8 9GS,
GB
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Vaistai, pasižymintys HM74A receptorių aktyvumu |
MEDICAMENTS WITH HM74A RECEPTOR ACTIVITY |
Payment date | Validity (years) | Amount | |
2017-01-17 | 13 | 289.00 EUR |
Patent lapsed (non-payment of fees) | ||
Invalidation date | 2018-02-10 |